Various pathways contribute to a cumulative pro-inflammatory state in MetS, with elevated Interleukin-6 (IL-6), C-reactive protein, and tumor necrosis factor alpha (TNFα) among these individuals. The gene discussed is TNF; the disease is metabolic syndrome.